Related Experiment Video

Updated: Jul 19, 2025

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
07:15

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Published on: August 23, 2024

472

Novel Antigens and Clinical Updates in Membranous Nephropathy

Rupali Avasare1, Nicole Andeen2, Laurence Beck3,4

  • 1Division of Nephrology and Hypertension, Oregon Health & Science University, Portland, Oregon, USA;

Annual Review of Medicine
|August 8, 2023
PubMed

Insights

Membranous nephropathy (MN) is an autoimmune kidney disease. Research is exploring new podocyte antigens beyond phospholipase A2 receptor (PLA2R) to improve patient care.

Area of Science:

  • Nephrology
  • Immunology
  • Autoimmune Diseases

Background:

  • Membranous nephropathy (MN) is a primary cause of nephrotic syndrome, potentially leading to kidney failure.
  • Autoimmunity targeting podocyte phospholipase A2 receptor (PLA2R) causes most MN cases.
  • PLA2R antibody levels are crucial for monitoring MN activity and treatment efficacy.

Purpose of the Study:

  • To review recent discoveries in MN target antigens.
  • To discuss the clinical significance of novel podocyte antigens in MN.
  • To hypothesize future directions for patient care based on current research.

Main Methods:

  • Literature review of recent findings in membranous nephropathy research.
  • Analysis of the clinical impact of newly identified podocyte antigens.
  • Synthesis of current research to inform future patient management strategies.

Main Results:

  • Over 20 additional podocyte antigens have been identified in MN.
  • The clinical relevance of these new antigens is currently under investigation.
  • PLA2R remains the primary target antigen in the majority of MN cases.

Conclusions:

  • Further research is needed to understand the role of novel antigens in MN.
  • Identifying additional antigens may refine diagnosis and treatment of MN.
  • Future care for MN patients may involve broader antigen testing and targeted therapies.
Keywords:
antibody-mediated kidney diseaseautoimmunitykidney diseasemembranous nephropathynephrotic syndromepodocyte antigens

More Related Videos

High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum10:19

High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum

Published on: November 23, 2013

16.3K
Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens09:57

Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens

Published on: February 14, 2011

12.0K

Related Concept Videos

Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
8
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
9
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
19
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
17
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
539